Anti-Human IGF1 and IGF2 Recombinant Antibody (Xentuzumab) (CAT#: TAB-475CQ)
Recombinant monoclonal antibody to IGF1 and IGF2. xentuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors. It neutralises IGF-1 and IGF-2 function.
Specific Inquiry
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized
- Type
- IgG1, λ1
- Specificity
- Human IGF1 and IGF2
- Species Reactivity
- Human
- Applications
- Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Neutralization
- Conjugate
- Unconjugated
- CAS
- 1417158-65-6
- Generic Name
- Xentuzumab
- UNII
- X86Z1O656G
- Related Disease
- Solid tumors
Product Property
- Purity
- > 95% as determined by SDS-PAGE
- Storage
- Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Target
Related Resources
Please refer to Xentuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Xentuzumab.
Endocrine Resistance
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Xentuzumab"
Afuco™ Anti-IGF1 and IGF2 ADCC Recombinant Antibody (Xentuzumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IGF1 and IGF2. xentuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors. It neutralises IGF-1 and IGF-2 function.
See other products for "IGF1 and IGF2"
ADCC Enhanced Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-475CQ | Afuco™ Anti-IGF1 and IGF2 ADCC Recombinant Antibody (Xentuzumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, Neut | ADCC enhanced antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-475CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.